Search Results - "Shete, Abhijit" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

by Gottlieb, Alice B, Deodhar, Atul, Mcinnes, Iain B, Baraliakos, Xenofon, Reich, Kristian, Schreiber, Stefan, Bao, Weibin, Marfo, Kwaku, Richards, Hanno B, Pricop, Luminita, Shete, Abhijit, Trivedi, Vivek, Keefe, Deborah, Papavassilis, Charis C, Jagiello, Piotr, Papanastasiou, Philemon, Mease, Philip J, Lebwohl, Mark
Published in Acta dermato-venereologica (27.04.2022)

Get full text

Journal Article

Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT

Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT

by Braun, Jürgen, Blanco, Ricardo, Marzo-Ortega, Helena, Gensler, Lianne S, van den Bosch, Filip, Hall, Stephen, Kameda, Hideto, Poddubnyy, Denis, van de Sande, Marleen, Wiksten, Anna S, Porter, Brian O, Shete, Abhijit, Richards, Hanno B, Haemmerle, Sibylle, Deodhar, Atul
Published in Arthritis research & therapy (04.09.2021)

Get full text

Journal Article

Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

Incidence of Uveitis in Secukinumab‐treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies

by Deodhar, Atul A., Miceli‐Richard, Corine, Baraliakos, Xenofon, Marzo‐Ortega, Helena, Gladman, Dafna D., Blanco, Ricardo, Das Gupta, Ayan, Martin, Ruvie, Safi, Jorge, Porter, Brian, Shete, Abhijit, Rosenbaum, James T.
Published in ACR open rheumatology (01.05.2020)

Get full text

Journal Article

Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan

Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan

by Shete, Abhijit, Shaikh, Aheson, Nayeem, K Javeed, Rodrigues, Lily, Ali, Mohamed Sheikamunadeen Sadiq, Shah, Parag, Khanna, Rajiv, Majid, Sarfaraj, Rasheed, Sabeer A, Shaikh, Shehla, Rahman, Tawfiqur
Published in World journal of diabetes (15.12.2013)

Get full text

Journal Article

Role of Inflammation and High-Sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease and CKD: A Survey of Nephrologists: SA-PO366

Role of Inflammation and High-Sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease and CKD: A Survey of Nephrologists: SA-PO366

by Perkovic, Vlado, Cherney, David, Erazo Tapia, Edmundo, Gerward, Sofia, Sahay, Manisha, Shete, Abhijit Vilas, Marx, Nikolaus
Published in Journal of the American Society of Nephrology (01.10.2024)

Get full text

Journal Article

230 Understanding UK cardiologists’ perception of systemic inflammation and hsCRP in atherosclerotic cardiovascular disease and chronic kidney disease: insights from UK respondents to the multinational flame-ASCVD survey

230 Understanding UK cardiologists’ perception of systemic inflammation and hsCRP in atherosclerotic cardiovascular disease and chronic kidney disease: insights from UK respondents to the multinational flame-ASCVD survey

by Pathak, Suraj, Catapano, Alberico L, Komuro, Issei, Marx, Nikolaus, Prasad, Preethy, Qian, Juying, Saraiva, José Francisco K, Shete, Abhijit, Mohseni Zonoozi, Amir A
Published in Heart (British Cardiac Society) (01.06.2024)

Get full text

Journal Article

Abstract 12463: Awareness and Perceptions Towards Inflammatory Risk in Atherosclerotic Cardiovascular Disease: A Multinational Survey Amongst Cardiologists

Abstract 12463: Awareness and Perceptions Towards Inflammatory Risk in Atherosclerotic Cardiovascular Disease: A Multinational Survey Amongst Cardiologists

by Marx, Nikolaus, Komuro, Issei, Mohseni Zonoozi, Amir A, Prasad, Preethy, Qian, Juying, Saraiva, Jose F, Shete, Abhijit V, Catapano, Alberico L
Published in Circulation (New York, N.Y.) (07.11.2023)

Get full text

Journal Article

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

by Elewski, Boni E, Baddley, John W, Deodhar, Atul A, Magrey, Marina, Rich, Phoebe A, Soriano, Enrique R, Soung, Jennifer, Bao, Weibin, Keininger, Dorothy, Marfo, Kwaku, Patekar, Manmath, Sharma, Abhishek, Shete, Abhijit, Lebwohl, Mark Gabriel
Published in JAMA dermatology (Chicago, Ill.) (01.01.2021)

Get more information

Journal Article

Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long‐Term Results of Two Phase III Randomized Controlled Trials

Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long‐Term Results of Two Phase III Randomized Controlled Trials

by Kvien, Tore K., Conaghan, Philip G., Gossec, Laure, Strand, Vibeke, Østergaard, Mikkel, Poddubnyy, Denis, Williams, Nicole, Porter, Brian, Shete, Abhijit, Gilloteau, Isabelle, Deodhar, Atul
Published in Arthritis care & research (2010) (01.05.2022)

Get full text

Journal Article

Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis

Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis

by Deodhar, Atul, Gladman, Dafna D, McInnes, Iain B, Spindeldreher, Sebastian, Martin, Ruvie, Pricop, Luminita, Porter, Brian, Safi, Jr, Jorge, Shete, Abhijit, Bruin, Gerard
Published in Journal of rheumatology (01.04.2020)

Get more information

Journal Article

Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase 3 Studies

Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase 3 Studies

by Schett, Georg, Baraliakos, Xenofon, Van den Bosch, Filip, Deodhar, Atul, Østergaard, Mikkel, Das Gupta, Ayan, Mpofu, Shephard, Fox, Todd, Winseck, Adam, Porter, Brian, Shete, Abhijit, Gensler, Lianne S
Published in Journal of rheumatology (15.03.2021)

Get more information

Journal Article

P190 Secukinumab improves back pain, morning stiffness, fatigue and physical function in tumour necrosis factor inhibitor-naive patients with non-radiographic axial spondyloarthritis: results from a randomised controlled Phase 3 study

P190 Secukinumab improves back pain, morning stiffness, fatigue and physical function in tumour necrosis factor inhibitor-naive patients with non-radiographic axial spondyloarthritis: results from a randomised controlled Phase 3 study

by Marzo-Ortega, Helena, Deodhar, Atul, Blanco, Ricardo Alonso, Kameda, Hideto, Kivitz, Alan, Poddubnyy, Denis, Magrey, Marina N, Wang, Jianyuan, Haemmerle, Sibylle, Shete, Abhijit, Braun, Jürgen
Published in Rheumatology (Oxford, England) (25.04.2021)

Get full text

Journal Article

P248 Subcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years

P248 Subcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years

by Marzo-Ortega, Helena, Miceli-Richard, Corinne, Gill, Sonja, Magery, Marina, Machado, Paula G. P, Shete, Abhijit, Wang, Jianyuan, Rohrer, Susanne, Deodhar, Atul
Published in Rheumatology (Oxford, England) (01.04.2020)

Get full text

Journal Article

Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia

Initial combination therapy with vildagliptin plus metformin in drug-naïve patients with T2DM: a 24-week real-life study from Asia

by Chawla, Manoj, Kim, Tae Ho, Mirasol, Roberto C, Faruque, Pathan, Cooke, Kathryn, Hours-Zesiger, Peggy, Shete, Abhijit
Published in Current medical research and opinion (02.09.2018)

Get more information

Journal Article

P191 Secukinumab demonstrates a consistent safety profile in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis over long term: updated pooled safety analyses

by McInnes, Iain B, Baraliakos, Xenofon, Deodhar, Atul, Gottlieb, Alice B, Lebwohl, Mark, Schreiber, Stefan, Marfo, Kwaku, Bao, Weibin, Richards, Hanno B, Pricop, Luminita, Shete, Abhijit, Safi, Jorge, Mease, Philip J
Published in Rheumatology (Oxford, England) (25.04.2021)

Get full text

Journal Article

FRI0388 SECUKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS, IRRESPECTIVE OF TIME SINCE FIRST DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM

FRI0388 SECUKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS, IRRESPECTIVE OF TIME SINCE FIRST DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM

by Deodhar, Atul, Boonen, Annelies, Ferraccioli, Gianfranco, Bosch, Filip van den, Martinez, David, Porter, Brian, Shete, Abhijit, Gilloteau, Isabelle, Yocolly, Aurore, Strand, Vibeke
Published in Annals of the rheumatic diseases (01.06.2019)

Get full text

Journal Article

263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period

263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period

by McInnes, Iain B, Deodhar, Atul, Gladman, Dafna D, Ren, Mengyuan, Spindeldreher, Sebastian, Pricop, Luminita, Porter, Brian, Safi, Jorge, Shete, Abhijit, Bruin, Gerard
Published in Rheumatology (Oxford, England) (01.04.2019)

Get full text

Journal Article

260 Low incidence of both new-onset and flares of uveitis in secukinumab-treated patients with ankylosing spondylitis: clinical trial and post-marketing safety analysis

260 Low incidence of both new-onset and flares of uveitis in secukinumab-treated patients with ankylosing spondylitis: clinical trial and post-marketing safety analysis

by Marzo-Ortega, Helena, Deodhar, Atul, Miceli-Richard, Corinne, Baraliakos, Xenofon, Gladman, Dafna D, Martin, Ruvie, Safi, Jorge, Porter, Brian, Shete, Abhijit
Published in Rheumatology (Oxford, England) (01.04.2019)

Get full text

Journal Article

EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies

EP38 Secukinumab provides sustained improvement of enthesitis in patients with ankylosing spondylitis: pooled analysis of four pivotal Phase 3 studies

by Barkham, Nick, Schett, Georg, Baraliakos, Xenofon, van den Bosch, Filip, Deodhar, Atul, Gensler, Lianne S, Ǿstergaard, Mikkel, Agawane, Shital, Gupta, Ayan Das, Mpofu, Shephard, Fox, Todd, Winseck, Adam, Shete, Abhijit, Porter, Brian
Published in Rheumatology (Oxford, England) (01.04.2020)

Get full text

Journal Article

Glycomonoterpene-Functionalized Crack-Resistant Biocompatible Silk Fibroin Coatings for Biomedical Implants

Glycomonoterpene-Functionalized Crack-Resistant Biocompatible Silk Fibroin Coatings for Biomedical Implants

by Joseph, Emmanuel, Patil, Amrita, Hirlekar, Swarali, Shete, Abhijit, Parekh, Nimisha, Prabhune, Asmita, Nisal, Anuya
Published in ACS applied bio materials (18.02.2019)

Get full text

Journal Article